BlackRock Investment Management’s Lipocine LPCN Stock Holding History

BlackRock Investment Management’s Portfolio LPCN Stock Details LPCN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$230K	Hold	3,678	–	–	﹤0.01%	3218
2016 Q3	$279K	Sell	3,678 -11	-0.3%	-$681	﹤0.01%	3198
2016 Q2	$191K	Buy	3,689 +3,540	+2,376%	+$548K	﹤0.01%	3273
2016 Q1	$26K	Sell	149 -6	-4%	-$1.02K	﹤0.01%	3328
2015 Q4	$34K	Hold	155	–	–	﹤0.01%	3345
2015 Q3	$31K	Buy	155 +6	+4%	+$1.39K	﹤0.01%	3350
2015 Q2	$22K	Buy	149 +56	+60%	+$6.95K	﹤0.01%	3410
2015 Q1	$11K	Hold	93	–	–	﹤0.01%	3620
2014 Q4	$8K	Hold	93	–	–	﹤0.01%	3757
2014 Q3	$10K	Buy	93 +2	+2%	+$249	﹤0.01%	3665
2014 Q2	$9K	Buy	+91	New	+$10.9K	﹤0.01%	3670

Other funds holding LPCN

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

VMI

VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock Investment Management's LPCN Position: Q4 2016 in Review

BlackRock Investment Management held its Lipocine (LPCN) position steady in Q4 2016 at 3,678 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #3218.

BlackRock Investment Management first reported a position in LPCN in Q2 2014 and has held it in 11 quarters since. The position peaked at $279K in Q3 2016. 58 funds tracked by Wall St. Rank hold LPCN as of Q4 2016.

BlackRock Investment Management held 3,678 shares of Lipocine worth $230K as of Q4 2016.
BlackRock Investment Management left its Lipocine share count unchanged in Q4 2016.
Lipocine made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3218 holding.
BlackRock Investment Management first reported a position in Lipocine in Q2 2014 and has held it in 11 quarters since.
BlackRock Investment Management's Lipocine position peaked at $279K in Q3 2016.
58 funds tracked by Wall St. Rank held Lipocine as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.